Blog / Archives
Rayno Life Science Portfolio Flash Update: Roche and FMI Merger; Update with XBI breakout
Rayno Life Science Portfolio FMI: Personalized Medicine for Oncology We are on vacation this week but need to update you on Roche (RHHBY) complete buyout of Foundation Medicine (FMI) one of our top...
Mid-Cap Biotech Watch List: Updated 6/12/18 After Huge ASCO Rally
Updated 6/18 pre-market Biotech Update for Week Ending 6/15 A relatively quiet less volatile week with the bullish trend intact at "triple-top" with XBI at $97 level. However, NASDAQ weakness...
Biotech Mid-Cap Momentum Leaders and Laggards…Update…gene editing
Update-1 Gene Editing stocks are hit hard by a STAT Report that edited cells may cause cancer. Here is a later summary from STAT. As of 2:45 PDT trading; CRSP down 12% at $60, EDIT down 7.8% at...
ASCO 2018 Biotech Rally Part 2 : Traders Take Profits on Nice Gains…Updates
ASCO 2018 Rally Part 2: Traders Take Profits on Nice Gains Biotech Indices and ETFs Show Gains YTD: FBIOX up 8% YTD, IBB up 3.13%, XBI up 9.34% The ASCO 2018 biotech rally was almost according to...
ASCO 2018 Biotech Rally : Teetering at the Top But a Leading Sector
ASCO 2018 Biotech Rally: Biotechs, Techs, and Semis Lead Market Higher Mid-Caps show huge gains but with high volatility. FBT at 142.91, IBB lagging at $110.52, XBI leading at $97.77 IWC Micro-Cap...
Mid-Cap Biotechs Lead the Market: Pre-ASCO Scoreboard…Updates 6/4/18
6/4/18...after close Update-2...IBB down 0.65%, XBI down 0.22%. Momentum Waning Big Winners Today : BLUE, FMI, GHDX, IMMU, MRK It would appear that biotech stocks need to be bought prior to ASCO as...
Financial and Political Crisis in Italy Disrupts Biotech Stock Momentum…Updates with rally today 5/30
Updates 5/30 Pre-ASCO Rally: XBI regains momentum to $94 level. IBB breaks through SMA 200 level to $108+. Many mid-caps from our watch list soaring-CRSP*, FMI, FOLD, LGND, LOXO, NKTR, SGEN, SRPT...
Biotech Mid-Caps: The Momentum Trade is Back FMI, LOXO,XBI etc
Biotech Mid-Caps- Momentum Trade is Back ASCO Abstracts Provide Clinical Updates But as of 2 P EDT Stocks Are Being Hit By Profit Taking XBI at $92.39 Biotech mid-caps had a good week ending 5/18 as...
Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should Outperform…Updates
Update: 5/17...Mini-Rally Continues With Help From ASCO Abstracts XBI hits $93.78 above April highs, up 5.32% over 5 days, 10.5% YTD. IBB at April highs at $107.59, up 3.62% over 5 days, up 0.77%...
Biotech Stocks Underperform Market: CELG, EXEL, PBYI, XBI…Updates 5/11…Big Rally on Drug Pricing Speech
Trump Speech on Plan for Lower Drug Prices 5/11 After close. Biotech and healthcare stocks were broadly higher. Key words by HHS Secretary were "complex" and "will take time"; more updates tomorrow....